Compounds > 1-nitrohydroxyphenyl-n-benzoylalanine
Page last updated: 2024-09-05

1-nitrohydroxyphenyl-n-benzoylalanine and thymalfasin

1-nitrohydroxyphenyl-n-benzoylalanine has been researched along with thymalfasin in 1 studies

Compound Research Comparison

Studies
(1-nitrohydroxyphenyl-n-benzoylalanine)		Trials
(1-nitrohydroxyphenyl-n-benzoylalanine)		Recent Studies (post-2010)
(1-nitrohydroxyphenyl-n-benzoylalanine)		Studies
(thymalfasin)		Trials
(thymalfasin)		Recent Studies (post-2010) (thymalfasin)
4203659180170

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Argaw-Denboba, A; Balestrieri, E; Garaci, E; Giovinazzo, A; Mandaliti, W; Matteucci, C; Nepravishta, R; Paci, M; Petrone, V; Pica, F; Sinibaldi-Vallebona, P1

Other Studies

1 other study(ies) available for 1-nitrohydroxyphenyl-n-benzoylalanine and thymalfasin

ArticleYear
Thymosin α1 interacts with Galectin-1 modulating the β-galactosides affinity and inducing alteration in the biological activity.
    International immunopharmacology, 2023, Volume: 118

    Topics: Galectin 1; Humans; Neoplasms; Thymalfasin; Thymosin

2023